Clinical Trials on Recurrent Adult Hodgkin's Lymphoma in Russian Federation
Total 101 results
-
Tomsk National Research Medical Center of the Russian...Uppsala UniversityCompletedHodgkin Lymphoma, Adult | Non-Hodgkin Lymphoma, AdultRussian Federation
-
State Budgetary Healthcare Institution, National...RecruitingHodgkin Lymphoma, AdultRussian Federation
-
St. Petersburg State Pavlov Medical UniversityCompletedHodgkin's LymphomaRussian Federation
-
Federal Research Institute of Pediatric Hematology...RecruitingHodgkin's LymphomaRussian Federation
-
CytokineticsCompletedNon-Hodgkin's Lymphoma | Hodgkin's DiseaseUnited States, Russian Federation
-
Federal Research Institute of Pediatric Hematology...RecruitingBurkitt Lymphoma | Diffuse Large B-cell Lymphoma | Primary CNS Lymphoma | Primary Mediastinal Lymphoma | Non-hodgkin Lymphoma,B CellRussian Federation
-
Multinational Center for Quality of Life Research...UnknownRelapsed or Refractory Hodgkin's LymphomaRussian Federation
-
National Research Center for Hematology, RussiaUnknownPh-negative Adult Acute Lymphoblastic LeukemiaRussian Federation
-
National Research Center for Hematology, RussiaRecruiting
-
State Budgetary Healthcare Institution, National...CompletedHodgkin LymphomaRussian Federation
-
National Research Center for Hematology, RussiaUnknown
-
Elena N.ParovichnikovaRecruiting
-
National Research Center for Hematology, RussiaNational Research Center for HematologyRecruiting
-
St. Petersburg State Pavlov Medical UniversityCompletedHodgkin LymphomaRussian Federation
-
St. Petersburg State Pavlov Medical UniversityN.N. Petrov National Medical Research Center of OncologyRecruitingHodgkin LymphomaRussian Federation
-
St. Petersburg State Pavlov Medical UniversityCompletedDiffuse Large B Cell LymphomaRussian Federation
-
Federal Research Institute of Pediatric Hematology...RecruitingAcute Myeloid Leukemia | Myelodysplastic Syndromes | Acute Lymphoblastic Leukemia, in Relapse | Non-hodgkin Lymphoma | High Risk Acute Myeloid Leukemia | High Risk Acute Lymphoblastic Leukemia | Acute Biphenotypic Leukemia in RelapseRussian Federation
-
St. Petersburg State Pavlov Medical UniversityRecruiting
-
Biointegrator LLCCompletedLymphoma, Follicular | Lymphoma, Non-HodgkinRussian Federation
-
SecuraBioCompletedIndolent Non-Hodgkin LymphomaKorea, Republic of, Czechia, United States, United Kingdom, Italy, Poland, Russian Federation, Germany
-
TakedaCompletedHodgkin Disease | Lymphoma, Large-cell, AnaplasticRussian Federation
-
PfizerCompletedHodgkin Disease | Thrombocytopenia | Non-Hodgkin LymphomaUnited States, Russian Federation, Singapore, Australia, France, Hong Kong, Greece, Poland
-
Gilead SciencesTerminatedIndolent Non-Hodgkin's LymphomasUnited States, Korea, Republic of, Hungary, United Kingdom, Australia, Singapore, Japan, Taiwan, Israel, Italy, Spain, Czechia, Russian Federation, France, Poland, Romania, Germany, Portugal, Sweden
-
Gilead SciencesTerminatedIndolent Non-Hodgkin's LymphomasUnited States, Korea, Republic of, Canada, Spain, Taiwan, France, Australia, United Kingdom, Poland, Italy, Israel, Czechia, Germany, Russian Federation, Sweden
-
BiocadCompletedSplenic Marginal Zone Lymphoma | Nodal Marginal Zone Lymphoma | Follicular Non-Hodgkin's LymphomaIndia, Russian Federation, Colombia, South Africa, Ukraine
-
Merck Sharp & Dohme LLCActive, not recruitingHodgkin's Lymphoma | Primary Mediastinal Large B-cell Lymphoma (PMBCL)Canada, United States, Brazil, Czechia, France, Italy, Poland, Russian Federation, South Africa, Turkey, Ukraine
-
Novartis PharmaceuticalsCompletedHodgkin's LymphomaUnited States, Belgium, Germany, Canada, Singapore, Netherlands, France, Australia, Russian Federation, Israel, Brazil, Italy, New Zealand, Poland
-
Russian Academy of Medical SciencesRecruitingMelanoma | Hodgkin Lymphoma | Uveal Melanoma | Squamous Cell Lung CancerRussian Federation
-
PfizerCompletedNon-Hodgkin's LymphomaKorea, Republic of, Australia, Czechia, United States, Romania, Germany, France, Poland, Italy, Russian Federation, Serbia
-
Gilead SciencesTerminatedMultiple Myeloma | Non-Hodgkin's Lymphoma | Chronic Lymphocytic LeukemiaUnited States, Czech Republic, Russian Federation
-
PfizerUCB PharmaTerminatedLymphoma, FollicularBelgium, United States, Canada, Hong Kong, Korea, Republic of, Portugal, Spain, Poland, India, Argentina, Italy, Mexico, Russian Federation, South Africa
-
BiogenCompletedNon-Hodgkin's LymphomaSweden, Czech Republic, France, Russian Federation, Turkey, United Kingdom, Germany, Lithuania, Romania, United States, Austria
-
BeiGeneActive, not recruitingRelapsed/Refractory Follicular Non-Hodgkin LymphomaKorea, Republic of, New Zealand, United States, China, Taiwan, Spain, Italy, Australia, Canada, United Kingdom, Belarus, Bulgaria, Czechia, France, Germany, Poland, Russian Federation
-
CelgeneCelgene CorporationCompletedCutaneous T-cell LymphomaUnited States, France, Germany, Poland, Russian Federation, United Kingdom
-
Astellas Pharma Europe B.V.CompletedLymphoma, Non-HodgkinRussian Federation
-
Eli Lilly and CompanyCompletedLymphoma, Large Cell, DiffuseFrance, Germany, Russian Federation
-
Millennium Pharmaceuticals, Inc.Johnson & Johnson Pharmaceutical Research & Development, L.L.C.CompletedStudy of VELCADE and Rituximab in Patients With Relapsed or Refractory B-cell Non-Hodgkin's LymphomaNon-Hodgkin's LymphomaFrance, United States, Spain, Korea, Republic of, Australia, Israel, India, Thailand, China, Czech Republic, Belgium, New Zealand, Russian Federation, Finland, South Africa, United Kingdom, Italy, Brazil, Hungary, Puerto Rico, A... and more
-
Telios Pharma, Inc.Active, not recruitingChronic Lymphocytic Leukemia | Small Lymphocytic Lymphoma | Relapsed/Refractory B Cell Malignancies | Mantle Cell Lymphoma and Diffuse Large B Cell Lymphoma | Treatment-Naive B Cell MalignanciesUnited States, Poland, Ukraine, Hungary, Italy, Russian Federation, United Kingdom
-
CelgeneTerminatedNon-Hodgkin's Lymphoma | Mantle Cell LymphomaUnited States, Spain, United Kingdom, Germany, France, Czechia, Israel, Italy, Poland, Portugal, Puerto Rico, Russian Federation
-
Genentech, Inc.Roche Pharma AGCompletedNon-Hodgkin's LymphomaUnited States, Spain, France, Canada, United Kingdom, Austria, Belgium, Czechia, Russian Federation, Italy, Switzerland, Germany, Netherlands, Sweden
-
Janssen Research & Development, LLCPharmacyclics LLC.CompletedLymphomaUnited States, France, Ukraine, United Kingdom, China, Germany, Spain, Argentina, Belgium, Israel, Russian Federation, Turkey, Japan, Australia, Sweden, Korea, Republic of, Brazil, Puerto Rico, Poland
-
Hoffmann-La RocheInstitute of Cancer Research, United Kingdom; German Low Grade Lymphoma Study...CompletedNon-Hodgkin's LymphomaItaly, Belgium, Canada, United Kingdom, Australia, China, Germany, United States, Russian Federation, Spain, Taiwan, Israel, Czechia, Hungary, Japan, France, Finland, Sweden
-
Seagen Inc.Millennium Pharmaceuticals, Inc.No longer availableLymphoma, Non-Hodgkin | Lymphoma, T-Cell, Cutaneous | Lymphoma, Large-Cell, Anaplastic | Disease, HodgkinUnited States, United Kingdom, Belgium, Serbia, Australia, Bulgaria, France, Germany, Hungary, Italy, Poland, Romania, Russian Federation, Spain, Switzerland
-
Hoffmann-La RocheCompletedNon-Hodgkin's LymphomaItaly, United Kingdom, Belgium, Brazil, Denmark, France, Peru, Colombia, Canada, Georgia, Singapore, Spain, Thailand, Australia, Germany, Mexico, Russian Federation, South Africa, Finland, Bosnia and Herzegovina, Bulgaria, Croatia, ... and more
-
Hoffmann-La RocheCompletedNon-Hodgkin's LymphomaItaly, Brazil, Slovenia, Spain, Germany, Switzerland, Russian Federation, Israel, Sweden, Albania, Argentina, Australia, Bosnia and Herzegovina, Bulgaria, Colombia, Croatia, Ecuador, Egypt, Finland, Greece, Mexico, Romania, Slovakia, ...
-
Hoffmann-La RocheCompletedNon-Hodgkin's LymphomaItaly, Russian Federation, United Kingdom, Brazil, Ecuador, Germany, Slovenia, Spain, Norway, Switzerland, France, Hungary, Romania, Austria, Albania, Bulgaria, Slovakia, Sweden, Turkey, Argentina, Colombia, Greece, Egypt, Lithuania
-
CTI BioPharmaCompletedDiffuse Large B-cell Lymphoma | de Novo DLBCL | DLBCL Transformed From Indolent Lymphoma | Follicular Grade 3 LymphomaUnited States, Germany, Italy, United Kingdom, Hungary, France, Spain, Ukraine, Czechia, Austria, Belgium, Bulgaria, Denmark, Poland, Romania, Russian Federation, Slovakia
-
Boehringer IngelheimCompletedLymphoma, FollicularSpain, Belgium, Czechia, France, Croatia, Germany, Austria, New Zealand, Australia, Greece, Hungary, Poland, Russian Federation
-
BayerCompletedLymphoma, Non-HodgkinTaiwan, Russian Federation, Brazil, Bulgaria, Korea, Republic of, Poland, Italy, Greece, Turkey, South Africa
-
Merck Sharp & Dohme LLCActive, not recruitingClassical Hodgkin LymphomaPoland, United States, Australia, Canada, Chile, France, Israel, Italy, Russian Federation, Spain, Turkey